Yonatan Grad
@yhgrad.bsky.social
Prof @ Harvard Chan School of Public Health. Antimicrobial resistance, STIs, N. gonorrhoeae, pandemic preparedness/response, pathogen genomics, mathematical modeling, ID epi
Congratulations! Wonderful news!
November 14, 2025 at 1:20 PM
Congratulations! Wonderful news!
Or folks from the micro lab? Maybe @sanjatkanjilal.bsky.social?
November 5, 2025 at 11:21 PM
Or folks from the micro lab? Maybe @sanjatkanjilal.bsky.social?
Not sure! Perhaps pulm / critical care folks could weigh in?
November 5, 2025 at 11:19 PM
Not sure! Perhaps pulm / critical care folks could weigh in?
Reposted by Yonatan Grad
…is totally missing the point of publishing scientific articles. Science is always a work in progress, never a finished story. We share our observations so that others can test & build on them, to advance collective understanding. AI may not be able to comprehend this but journals and reviewers MUST
November 3, 2025 at 10:38 PM
…is totally missing the point of publishing scientific articles. Science is always a work in progress, never a finished story. We share our observations so that others can test & build on them, to advance collective understanding. AI may not be able to comprehend this but journals and reviewers MUST
I think they’re all worth considering, and of course it’s likely multifactorial and even changing as new interventions are introduced—hence this piece! Shifting behaviors? Bexsero? Doxy-PEP?
September 28, 2025 at 2:46 PM
I think they’re all worth considering, and of course it’s likely multifactorial and even changing as new interventions are introduced—hence this piece! Shifting behaviors? Bexsero? Doxy-PEP?
People have their favorite explanations, but it's not clear--and without a better understanding of what's driving these trends, we won't be able to optimally inform public health interventions. We lay out the possibilities and how to address them for gonorrhea. (2/2) dash.harvard.edu/entities/pub...
Why are gonorrhea diagnoses declining in the US?
After a decade of rising cases, the US CDC reported a decline in the rate of gonorrhea diagnoses for two years in a row in 2022 and 2023, especially among young adults. Primary and secondary syphilis ...
dash.harvard.edu
September 27, 2025 at 4:54 PM
People have their favorite explanations, but it's not clear--and without a better understanding of what's driving these trends, we won't be able to optimally inform public health interventions. We lay out the possibilities and how to address them for gonorrhea. (2/2) dash.harvard.edu/entities/pub...
Interesting to think about implications for assessment of trends in incidence / prevalence estimates with NAAT overcalling active infections.
July 28, 2025 at 12:13 PM
Interesting to think about implications for assessment of trends in incidence / prevalence estimates with NAAT overcalling active infections.